Financials

News Discussions Technicals Seasonals

CRTX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to CRISM THERAPEUTICS CORPORATION ORD NPV operating, investing, and financing activities

CRTX free cash flow for H1 24 is -475 k GBP. For 2023, CRTX free cash flow was -2.23 M GBP and operating cash flow was -2.23 M GBP.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: GBP

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—